BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ventracor Limited (Formerly Micromedical Industries Ltd.) 

126 Greville Street

Chatswood  New South Wales  2067  Australia
Phone: 61-2-9406-3100 Fax: 61-2-9406-3101


SEARCH JOBS




Industry
Medical Device






 Company News
Ventracor Limited (VCR.AX) Views The Article in "The Australian" Newspaper As Incorrect And Misleading 2/18/2009 12:40:18 PM
Ventracor Limited (VCR.AX) Major Milestone - 78.6% Success in BTT Trial 2/2/2009 2:58:55 PM
Ventracor Limited (VCR.AX) Exploring Strategic Options 12/11/2008 1:42:26 PM
Ventracor Limited (VCR.AX) Announces Continuation of CEO Employment Contract 5/19/2008 2:42:50 PM
Ventracor Limited (VCR.AX) Announce 250th Implant of VentrAssist Left Ventricular Assist Device (LVAD) 5/6/2008 3:00:37 PM
Ventracor Limited (VCR.AX) Announce Results of US Feasibility Trial of the VentraAssist LVAD 4/14/2008 11:04:24 AM
Ventracor Limited (VCR.AX) Announce Election of John Ward to Chairman 4/3/2008 4:29:03 PM
Ventracor Limited (VCR.AX) (ASX:VCR) CEO Peter Crosby Letter to Shareholders 4/3/2008 4:27:50 PM
Ventracor Limited (VCR.AX) Announce US FDA Unconditional Approval of Destination Therapy Trial For LVAD 3/17/2008 2:30:12 PM
Ventracor Limited (VCR.AX) Appoints Destination Therapy Trial Principal Investigator For LVAD 3/13/2008 3:58:14 PM
12345